Dermatologic manifestations associated with electronic cigarette use.
Individual Clinical
Safety
Adverse Effects
Visconti (2019)
On the toxicity of e-cigarettes consumption: Focus on pathological cellular mechanisms.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Vivarelli (2022)
Measuring e-cigarette addiction among adolescents.
Individual Clinical
Biomarkers
Biomarkers Of Harm
Vogel (2020)
Prevalence of and disparities in adolescents' susceptibility to novel oral nicotine products marketed as "tobacco-free".
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Vogel (2023)
Comparison of self-rated oral symptoms and periodontal status among cigarette smokers and individuals using electronic nicotine delivery systems.
Individual Clinical
Safety
Adverse Effects
Vohra (2020)
What is the nicotine delivery profile of electronic cigarettes?
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Voos (2019)
Effect of e-cigarette flavors on nicotine delivery and puffing topography: results from a randomized clinical trial of daily smokers.
Individual Clinical
User Topography
Voos (2020)
associated Changes in E-cigarette Puff Duration and Cigarettes Smoked per Day.
Individual Clinical
User Topography
Wagener (2021)
Estimating the Population attributable Fraction of asthma Due to Electronic Cigarette Use and Other Risk Factors Using Kentucky Behavioral Risk Factor Survey Data, 2016-2017.
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of User
Walker (2021)